ArticleIUBMB life2019

Ubiquitin-independent, Proteasome-mediated targeted degradation of KRAS in pancreatic adenocarcinoma cells using an engineered ornithine decarboxylase/antizyme system.

Yihui Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.